UG Healthcare Corporation Limited (SGX:8K7)

UG Healthcare Corporation Statistics

Total Valuation

SGXC:8K7 has a market cap or net worth of SGD 57.39 million. The enterprise value is 74.45 million.

Market Cap	57.39M
Enterprise Value	74.45M

Important Dates

The last earnings date was Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

SGXC:8K7 has 623.83 million shares outstanding.

Current Share Class	623.83M
Shares Outstanding	623.83M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.74%
Owned by Institutions (%)	2.99%
Float	216.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.39
PB Ratio	0.35
P/TBV Ratio	0.40
P/FCF Ratio	10.47
P/OCF Ratio	6.61
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.12, with an EV/FCF ratio of 13.58.

EV / Earnings	-17.29
EV / Sales	0.51
EV / EBITDA	22.12
EV / EBIT	n/a
EV / FCF	13.58

Financial Position

The company has a current ratio of 3.00, with a Debt / Equity ratio of 0.27.

Current Ratio	3.00
Quick Ratio	1.79
Debt / Equity	0.27
Debt / EBITDA	13.10
Debt / FCF	7.96
Interest Coverage	-0.74

Financial Efficiency

Return on equity (ROE) is -2.50% and return on invested capital (ROIC) is -1.01%.

Return on Equity (ROE)	-2.50%
Return on Assets (ROA)	-0.50%
Return on Invested Capital (ROIC)	-1.01%
Return on Capital Employed (ROCE)	-0.99%
Weighted Average Cost of Capital (WACC)	7.12%
Revenue Per Employee	174,541
Profits Per Employee	-5,143
Employee Count	837
Asset Turnover	0.63
Inventory Turnover	1.88

Taxes

In the past 12 months, SGXC:8K7 has paid 615,000 in taxes.

Income Tax	615,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.69% in the last 52 weeks. The beta is 0.89, so SGXC:8K7's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	-20.69%
50-Day Moving Average	0.09
200-Day Moving Average	0.10
Relative Strength Index (RSI)	44.48
Average Volume (20 Days)	680,570

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SGXC:8K7 had revenue of SGD 146.09 million and -4.31 million in losses. Loss per share was -0.01.

Revenue	146.09M
Gross Profit	34.24M
Operating Income	-1.84M
Pretax Income	-3.43M
Net Income	-4.31M
EBITDA	2.72M
EBIT	-1.84M
Loss Per Share	-0.01

Balance Sheet

The company has 23.87 million in cash and 43.64 million in debt, with a net cash position of -19.77 million or -0.03 per share.

Cash & Cash Equivalents	23.87M
Total Debt	43.64M
Net Cash	-19.77M
Net Cash Per Share	-0.03
Equity (Book Value)	162.79M
Book Value Per Share	0.27
Working Capital	85.70M

Cash Flow

In the last 12 months, operating cash flow was 8.68 million and capital expenditures -3.19 million, giving a free cash flow of 5.48 million.

Operating Cash Flow	8.68M
Capital Expenditures	-3.19M
Free Cash Flow	5.48M
FCF Per Share	0.01

Margins

Gross margin is 23.44%, with operating and profit margins of -1.26% and -2.95%.

Gross Margin	23.44%
Operating Margin	-1.26%
Pretax Margin	-2.35%
Profit Margin	-2.95%
EBITDA Margin	1.86%
EBIT Margin	-1.26%
FCF Margin	3.75%

Dividends & Yields

SGXC:8K7 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-7.50%
FCF Yield	9.56%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 30, 2020. It was a forward split with a ratio of 3.

Last Split Date	Sep 30, 2020
Split Type	Forward
Split Ratio	3

Scores

SGXC:8K7 has an Altman Z-Score of 2.71 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.71
Piotroski F-Score	5